Adcetris
Generic: brentuximab vedotin
Manufacturer: Pfizer · Program: Pfizer Oncology Together
Apply for AssistanceEligibility Criteria
Insurance Requirement
Commercially insured patients; excludes Medicare, Medicaid, TRICARE, VA, state/federal programs
Residency
US resident
Income Threshold
Up to 300% FPL
Individual Income Limit
$43,740/year
Must be uninsured or publicly insured; commercial insurance ineligible
Program Information
Processing Time
2–4 weeks after complete application received
Delivery Method
shipped to patient
Application Method
Multiple
Reauthorization
Required, annual
Indicated For
classical Hodgkin lymphoma (cHL), systemic anaplastic large cell lymphoma (sALCL), CD30-expressing peripheral T-cell lymphomas (PTCL)
About This Medication
# Pfizer Oncology Together Patient Guide: How to Get Adcetris (brentuximab vedotin) at Low or No Cost Facing a cancer diagnosis is challenging enough without worrying about medication costs. The **Pfizer Oncology Together** program helps **commercially insured patients** access **Adcetris (brentuximab vedotin)**, a targeted therapy for certain lymphomas, by reducing out-of-pocket expenses to **as little as $0 per treatment**, up to **$15,000 in annual savings**.[1][3] ## About Adcetris (brentuximab vedotin) **Adcetris** is an injectable chemotherapy drug that targets CD30-positive cancer cells. It's a **conjugate**—an antibody linked to a toxin—that delivers treatment directly to lymphoma cells while sparing healthy ones, potentially reducing side effects compared to traditional chemotherapy.[1] Adcetris is FDA-approved for several serious conditions, including: - Previously untreated **Stage III/IV classical Hodgkin lymphoma (cHL)** in combination with other drugs like doxorubicin, vinblastine, and dacarbazine. - Previously untreated **systemic anaplastic large cell lymphoma (sALCL)** or other CD30-expressing peripheral T-cell lymphomas (PTCL), combined with cyclophosphamide, doxorubicin, and prednisone. - Relapsed **sALCL** after prior chemotherapy. - **Primary cutaneous anaplastic large cell lymphoma (pcALCL)** or CD30-expressing **mycosis fungoides (MF)** after systemic therapy. - Relapsed or refractory **large B-cell lymphoma (LBCL)** after multiple therapies, in combination with lenalidomide and rituximab.[1] Your doctor prescribes Adcetris based on your specific diagnosis and medical history. It's administered by a healthcare professional, typically every 2-3 weeks via IV infusion.[1] ## Who Qualifies for Pfizer Oncology Together? This program is a **co-pay savings program**, not free medication. It covers copays, coinsurance, and deductibles for eligible patients.[2][3] ### Key Eligibility Requirements - **Commercial insurance** only (private plans from employers or marketplace like Blue Cross, UnitedHealthcare).[1][2] - **No government insurance**: Excludes Medicare, Medicaid, TRICARE, VA benefits, Social Security Disability, or other federal/state programs.[2] - **U.S. resident** with a valid prescription for Adcetris. - Agree to program **terms and conditions**.[2] **Income eligibility**: No strict household income limits (FPL-based thresholds not specified). However, Pfizer verifies financial need during enrollment and may connect you to additional resources if needed.[3][7] | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | Not specified | Focus on commercial insurance; savings up to $15,000/year. | | Couple | Not specified | Excludes government benefits. | | Family of 3 | Not specified | Program prioritizes copay reduction. | | Family of 4+ | Not specified | Contact program for personalized review. | *Table note: Unlike free drug programs, this co-pay assistance has flexible income review but strict insurance rules.*[1][2][3] ## Insurance Requirements **Must have commercial insurance** covering Adcetris. Government programs are **not eligible**—patients on Medicare Part D, Medicaid, or VA may explore Pfizer RxPathways for other options.[2][8] - **Exclusions**: TRICARE, military health, Social Security benefits.[2] - Pfizer's team verifies your benefits, checks prior authorizations, and appeals denials.[7][9] If uninsured or underinsured, ask your doctor about Pfizer's **Patient Assistance Program** (separate from co-pay savings).[10] ## Step-by-Step Application Process Enrollment is straightforward and can be done **online, by phone, fax, or through your doctor**.[6][7][9] 1. **Discuss with your doctor**: Confirm Adcetris prescription and commercial insurance. Ask them to enroll you via the Provider Portal.[7] 2. **Sign up yourself**: - Visit **PfizerOncologyTogether.com/patient/sign-up**.[2][4] - Select **Adcetris** and complete the form with insurance details. - Or call **1-877-744-5675** (Mon-Fri, 8 AM–8 PM ET).[2][9] 3. **Your doctor enrolls**: - Download the **Adcetris Enrollment Form** from PfizerOncologyTogether.com/hcp/enroll.[5][9] - Fax to 1-877-736-6506 or submit online via Provider Portal.[6][7] 4. **Pfizer reviews**: They verify eligibility, benefits, and issue a **co-pay card** (digital or physical).[6] 5. **Use your card**: Present at infusion center; savings apply automatically (up to $15,000/year).[1][3] **Multiple methods** make it accessible—patient or HCP-led.[7] ## Timeline and Delivery - **Processing**: Benefit verification and approval often within days; full enrollment 1-2 weeks.[6][7] - **Delivery**: Adcetris is **shipped to your doctor's office or infusion center**—never directly to home. Program doesn't handle drug shipping; it covers costs.[1] - **First dose**: Use co-pay card at administration. **Reauthorization required**: Periodic review (e.g., annually or per treatment course) to confirm ongoing eligibility.[program details] ## If Denied or Need Alternatives **Common denial reasons**: Government insurance, max savings reached, or expired eligibility.[2] - **Appeal**: Pfizer's **Field Reimbursement Directors (FRDs)** or **Patient Access Navigators** help with appeals, prior auths, and alternative funding (Mon-Fri support).[1][7] - **Other Pfizer options**: Pfizer RxPathways for uninsured/low-income (proof of income needed; 2-3 weeks processing).[10] - **No biosimilars** available for Adcetris currently.[program details] - **External resources**: NeedyMeds, PAN Foundation, or CancerCare grants. Contact **1-877-744-5675** for personalized navigation.[2] ## Important Disclaimer This guide is for informational purposes only and based on publicly available program details as of latest updates. **Eligibility, benefits, and terms can change**—Pfizer reserves the right to modify/revoke without notice.[2] Always verify with Pfizer Oncology Together at 1-877-744-5675 or PfizerOncologyTogether.com. **Not health insurance**; max $15,000 savings per year. Consult your doctor for medical advice. Not affiliated with Pfizer.[1][2][3] *Word count: ~950*
Program information last verified: March 30, 2026
Ready to apply for Adcetris assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.